Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis

Stem Cell Reviews and Reports

Volumn 11, Issue 3, 2015, Pages 442-452

  Najar, Mehdi ^a   Raicevic, Gordana ^a   Fayyad Kazan, Hussein ^a   De Bruyn, Cécile ^a   Bron, Dominique ^a   Toungouz, Michel ^a   Lagneaux, Laurence ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

BM MSCs; CD210; Cell surface molecule; IL 10; T cell response; Treg

Indexed keywords

IL10 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA;

ADIPOSE TISSUE; BIOSYNTHESIS; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MESENCHYMAL STROMA CELL; METABOLISM; REGULATORY T LYMPHOCYTE; SECRETION (PROCESS); T LYMPHOCYTE;

ADIPOSE TISSUE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTERLEUKIN-10; INTERLEUKIN-10 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MESENCHYMAL STROMAL CELLS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 84930376817     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-014-9567-3     Document Type: Article

References (62)

1. Gizinski, A. M., Fox, D. A., & Sarkar, S. (2010). Pharmacotherapy: concepts of pathogenesis and emerging treatments. Co-stimulation and T cells as therapeutic targets. Best Practice & Research. Clinical Rheumatology, 24, 463–477.
2. Chadburn, A., Inghirami, G., & Knowles, D. M. (1992). The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells. Hematologic Pathology, 6, 193–202.
3. Rowe, J. H., Ertelt, J. M., & Way, S. S. (2012). Foxp3(+) regulatory T cells, immune stimulation and host defence against infection. Immunology, 136, 1–10.
4. Gallucci, S., & Matzinger, P. (2001). Danger signals: SOS to the immune system. Current Opinion in Immunology, 13, 114–119.
5. Bluestone JA, Bour-Jordan H. (2012). Current and future immunomodulation strategies to restore tolerance in autoimmune diseases. Cold Spring Harb Perspect Biol, 4.
6. Mundra, V., Gerling, I. C., & Mahato, R. I. (2013). Mesenchymal stem cell-based therapy. Molecular Pharmaceutics, 10, 77–89.
7. English, K., & Wood, K. J. (2013). Mesenchymal stromal cells in transplantation rejection and tolerance. Cold Spring Harbor Perspective Medicine, 3, a015560.
8. Najar, M., Raicevic, G., Fayyad-Kazan, H., De Bruyn, C., Bron, D., Toungouz, M., & Lagneaux, L. (2012). Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming. Stem Cell Reviews, 8, 1188–1198.
9. Wang, L., Zhao, Y., & Shi, S. (2012). Interplay between mesenchymal stem cells and lymphocytes: implications for immunotherapy and tissue regeneration. Journal of Dental Research, 91, 1003–1010.
10. Ribeiro, A., Laranjeira, P., Mendes, S., Velada, I., Leite, C., Andrade, P., Santos, F., Henriques, A., Grãos, M., Cardoso, C. M., Martinho, A., Pais, M., da Silva, C., Cabral, J., Trindade, H., & Paiva, A. (2013). Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem Cell Research & Therapy, 4, 125.
11. Nasef, A., Chapel, A., Mazurier, C., Bouchet, S., Lopez, M., Mathieu, N., Sensebé, L., Zhang, Y., Gorin, N. C., Thierry, D., & Fouillard, L. (2007). Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expression, 13, 217–226.
12. Tee, J. Y., Vaghjiani, V., Liu, Y. H., Murthi, P., Chan, J., & Manuelpillai, U. (2013). Immunogenicity and immunomodulatory properties of hepatocyte-like cells derived from human amniotic epithelial cells. Current Stem Cell Research & Therapy, 8, 91–99.
13. La Rocca, G., Lo Iacono, M., Corsello, T., Corrao, S., Farina, F., & Anzalone, R. (2013). Human Wharton’s jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy. Current Stem Cell Research & Therapy, 8, 100–113.
14. Wang, R., Lu, M., Zhang, J., Chen, S., Luo, X., Qin, Y., & Chen, H. (2011). Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer. Journal of Experimental & Clinical Cancer Research, 30, 62.
15. Najar, M., Rouas, R., Raicevic, G., Boufker, H. I., Lewalle, P., Meuleman, N., Bron, D., Toungouz, M., Martiat, P., & Lagneaux, L. (2009). Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy, 11, 570–583.
16. Joss, A., Akdis, M., Faith, A., Blaser, K., & Akdis, C. A. (2000). IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. European Journal of Immunology, 30, 1683–1690.
17. Najar, M., Raicevic, G., Id Boufker, H., Stamatopoulos, B., De Bruyn, C., Meuleman, N., Bron, D., Toungouz, M., & Lagneaux, L. (2010). Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. Experimental Hematology, 38, 922–932.
18. Prevosto, C., Zancolli, M., Canevali, P., Zocchi, M. R., & Poggi, A. (2007). Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica, 92, 881–888.
19. Rasmusson, I., Ringdén, O., Sundberg, B., & Le Blanc, K. (2005). Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Experimental Cell Research, 305, 33–41.
20. Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E., & Rachmilewitz, J. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 105, 2214–2219.
21. Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815–1822.
22. Wong, C. K., Wong, P. T., Tam, L. S., Li, E. K., Chen, D. P., & Lam, C. W. (2010). Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus. Clinical and Experimental Immunology, 159(1), 11–22.
23. Suzuki, S., Mita, S., Kamohara, H., Sakamoto, K., Ishiko, T., & Ogawa, M. (2001). IL-6 and IFN-gamma regulation of IL-10 production by human colon carcinoma cells. International Journal of Oncology, 18(3), 581–586.
24. Foey, A. D., Parry, S. L., Williams, L. M., Feldmann, M., Foxwell, B. M., & Brennan, F. M. (1998). Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. Journal of Immunology, 160(2), 920–928.
25. Suva, D., Passweg, J., Arnaudeau, S., Hoffmeyer, P., & Kindler, V. (2008). In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them. Journal of Cellular Physiology, 214, 588–594.
26. Payne, N. L., Sun, G., McDonald, C., Moussa, L., Emerson-Webber, A., Loisel-Meyer, S., Medin, J. A., Siatskas, C., & Bernard, C. C. (2013). Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity. Brain, Behavior, and Immunity, 30, 103–114.
27. Glimcher, L. H., & Murphy, K. M. (2000). Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes and Development, 14, 1693–1711.
28. Asadullah, K., Sterry, W., & Volk, H. D. (2003). Interleukin-10 therapy–review of a new approach. Pharmacological Reviews, 55, 241–269.
29. Ding, Y., Qin, L., Zamarin, D., Kotenko, S. V., Pestka, S., Moore, K. W., & Bromberg, J. S. (2001). Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. Journal of Immunology, 167, 6884–6892.
30. Tamassia, N., Calzetti, F., Menestrina, N., Rossato, M., Bazzoni, F., Gottin, L., & Cassatella, M. A. (2008). Circulating neutrophils of septic patients constitutively express IL-10R1 and are promptly responsive to IL-10. International Immunology, 20, 535–541.
31. Moniuszko, M., Bodzenta-Lukaszyk, A., & Dabrowska, M. (2009). Oral glucocorticoid treatment decreases interleukin-10 receptor expression on peripheral blood leucocyte subsets. Clinical and Experimental Immunology, 156, 328–335.
32. Santner-Nanan, B., Straubinger, K., Hsu, P., Parnell, G., Tang, B., Xu, B., Makris, A., Hennessy, A., Peek, M. J., Busch, D. H., da Costa, C. P., & Nanan, R. (2013). Fetal-maternal alignment of regulatory T cells correlates with IL-10 and Bcl-2 upregulation in pregnancy. Journal of Immunology, 191(1), 145–153.
33. Jonuleit, H., & Schmitt, E. (2003). The regulatory T cell family: distinct subsets and their interrelations. Journal of Immunology, 171, 6323–6327.
34. Cope, A., Le Friec, G., Cardone, J., & Kemper, C. (2011). The Th1 life cycle: molecular control of IFN-γ to IL-10 switching. Trends in Immunology, 32, 278–286.
35. Moore, K. W., de Waal, M. R., Coffman, R. L., & O’Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology, 19, 683–765.
36. Akdis, C. A., & Blaser, K. (2001). Mechanisms of interleukin-10-mediated immune suppression. Immunology, 103, 131–136.
37. Sakaguchi, S., Wing, K., & Yamaguchi, T. (2009). Dynamics of peripheral tolerance and immune regulation mediated by Treg. European Journal of Immunology, 39, 2331–2336.
38. Ivanova-Todorova, E., Bochev, I., Dimitrov, R., Belemezova, K., Mourdjeva, M., Kyurkchiev, S., Kinov, P., Altankova, I., & Kyurkchiev, D. (2012). Conditioned medium from adipose tissue-derived mesenchymal stem cells induces CD4+ FOXP3+ cells and increases IL-10 secretion. Journal of Biomedicine and Biotechnology, 2012, 295167.
39. Liu, X., Qu, X., Chen, Y., Liao, L., Cheng, K., Shao, C., Zenke, M., Keating, A., & Zhao, R. C. (2012). Mesenchymal stem/stromal cells induce the generation of novel IL-10-dependent regulatory dendritic cells by SOCS3 activation. Journal of Immunology, 189(3), 1182–1192.
40. Chen, P. M., Liu, K. J., Hsu, P. J., Wei, C. F., Bai, C. H., Ho, L. J., Sytwu, H. K., & Yen, B. L. (2014). Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2. Journal of Leukocyte Biology, 96(2), 295–303.
41. Liu, W. H., Liu, J. J., Wu, J., Zhang, L. L., Liu, F., Yin, L., Zhang, M. M., & Yu, B. (2013). Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway. PLoS ONE, 8(1), e55487.
42. Németh, K., Leelahavanichkul, A., Yuen, P. S., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., Hu, X., Jelinek, I., Star, R. A., & Mezey, E. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Medicine, 15(1), 42–49.
43. Selmani, Z., Naji, A., Zidi, I., Favier, B., Gaiffe, E., Obert, L., Borg, C., Saas, P., Tiberghien, P., Rouas-Freiss, N., Carosella, E. D., & Deschaseaux, F. (2008). Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells, 26(1), 212–222.
44. Mougiakakos, D., Jitschin, R., Johansson, C. C., Okita, R., Kiessling, R., & Le Blanc, K. (2011). The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood, 117(18), 4826–4835.
45. Gieseke, F., Böhringer, J., Bussolari, R., Dominici, M., Handgretinger, R., & Müller, I. (2010). Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood, 116(19), 3770–3779.
46. Luo, C., Jia, W., Wang, K., Chi, F., Gu, Y., Yan, X., Zou, G., Duan, T., & Zhou, Q. (2014). Human amniotic fluid stem cells suppress PBMC proliferation through IDO and IL-10-dependent pathways. Current Stem Cell Research & Therapy, 9(1), 36–45.
47. Milwid, J. M., Elman, J. S., Li, M., Shen, K., Manrai, A., Gabow, A., Yarmush, J., Jiao, Y., Fletcher, A., Lee, J., Cima, M. J., Yarmush, M. L., & Parekkadan, B. (2014). Enriched protein screening of human bone marrow mesenchymal stromal cell secretions reveals MFAP5 and PENK as novel IL-10 modulators. Molecular Therapy, 22(5), 999–1007.
48. Burr, S. P., Dazzi, F., & Garden, O. A. (2013). Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance? Immunology and Cell Biology, 91(1), 12–18.
49. Jansen, B. J., Gilissen, C., Roelofs, H., Schaap-Oziemlak, A., Veltman, J. A., Raymakers, R. A., Jansen, J. H., Kögler, G., Figdor, C. G., Torensma, R., & Adema, G. J. (2010). Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells and Development, 19, 481–490.
50. Hwang, J. H., Shim, S. S., Seok, O. S., Lee, H. Y., Woo, S. K., Kim, B. H., Song, H. R., Lee, J. K., & Park, Y. K. (2009). Comparison of cytokine expression in mesenchymal stem cells from human placenta, cord blood, and bone marrow. Journal of Korean Medical Science, 24, 547–554.
51. Selleri, S., Dieng, M. M., Nicoletti, S., Louis, I., Beausejour, C., Le Deist, F., & Haddad, E. (2013). Cord-blood-derived mesenchymal stromal cells downmodulate CD4+ T-cell activation by inducing IL-10-producing Th1 cells. Stem Cells and Development, 22, 1063–1075.
52. Tong, C. K., Seow, H. F., & Ramasamy, R. (2008). Cord blood-derived mesenchymal stem cell does not stimulate nor inhibits T lymphocytes activation. The Medical Journal of Malaysia, 63(Suppl A), 77–78.
53. Najar, M., Raicevic, G., Fayyad-Kazan, H., De Bruyn, C., Bron, D., Toungouz, M., & Lagneaux, L. (2013). Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration. International Immunopharmacology, 15, 693–702.
54. Chen, L., & Flies, D. B. (2013). Molecular mechanisms of T cell co-stimulation and co-inhibition. Nature Reviews Immunology, 13, 227–242.
55. Cheng, G., Yu, A., Dee, M. J., & Malek, T. R. (2013). IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development. Journal of Immunology, 190, 1567–1575.
56. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J., & Lenardo, M. J. (2007). CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nature Immunology, 8, 1353–1362.
57. Sandoval-Montes, C., & Santos-Argumedo, L. (2005). CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines. Journal of Leukocyte Biology, 77, 513–521.
58. Oliveira, M. I., Gonçalves, C. M., Pinto, M., Fabre, S., Santos, A. M., Lee, S. F., Castro, M. A., Nunes, R. J., Barbosa, R. R., Parnes, J. R., Yu, C., Davis, S. J., Moreira, A., Bismuth, G., & Carmo, A. M. (2012). CD6 attenuates early and late signaling events, setting thresholds for T-cell activation. European Journal of Immunology, 42, 195–205.
59. Wakkach, A., Cottrez, F., & Groux, H. (2001). Differentiation of regulatory T cells 1 is induced by CD2 costimulation. Journal of Immunology, 167, 3107–3113.
60. Sims, T. N., & Dustin, M. L. (2002). The immunological synapse: integrins take the stage. Immunological Reviews, 186, 100–117.
61. Ghannam, S., Pène, J., Moquet-Torcy, G., Jorgensen, C., & Yssel, H. (2010). Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. Journal of Immunology, 185(1), 302–312.
62. Castro-Manrreza, M. E., Mayani, H., Monroy-García, A., Flores-Figueroa, E., Chávez-Rueda, K., Legorreta-Haquet, V., Santiago-Osorio, E., & Montesinos, J. J. (2014). Human mesenchymal stromal cells from adult and neonatal sources: a comparative in vitro analysis of their immunosuppressive properties against T cells. Stem Cells and Development, 23(11), 1217–1232.